...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
【24h】

Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.

机译:开发咪唑链烷酸作为mGAT3选择性GABA摄取抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A new series of potential GABA uptake inhibitors starting from of 1H-imidazol-4-ylacetic acid with the carboxylic acid side chain originating from different positions and varying in length have been synthesized and tested for the inhibitory potency at the four GABA uptake transporters mGAT1-4 stably expressed in HEK cells. Further two bicyclic compounds with a rigidified carboxylic acid side chain were included in this study. The results of the biological tests indicated that most omega-imidazole alkanoic and alkenoic acid derivatives exhibit the highest potencies as GABA uptake inhibitors at mGAT3.
机译:合成了一系列新的潜在的GABA吸收抑制剂,这些抑制剂从1H-咪唑-4-基乙酸开始,羧酸侧链起源于不同的位置,且长度不同,并在四个GABA吸收转运蛋白mGAT1-上测试了其抑制能力。 4在HEK细胞中稳定表达。该研究还包括另外两个具有刚性羧酸侧链的双环化合物。生物学测试结果表明,大多数ω-咪唑链烷酸和链烯酸衍生物作为mGAT3的GABA吸收抑制剂表现出最高的效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号